Transforming microbiome data into novel scientific discoveries
Explore our technology designed to meet your R&D needs and elevate your microbiome research
Leveraging insights from the gut
The human gastrointestinal tract hosts a diverse and complex community of microorganisms. The microbiota composition differs across regions of the GI tract, yet most research has focused primarily on that residing in the fecal and colonic mucosa. However, one significant limitation of fecal sampling to determine the intestinal microbial composition is the fact that they only reflect the end of the colon, leaving other regions of the GI tract, particularly the small intestine, which is difficult to access, largely unexplored.
Uncovering the power of the small intestine
The small intestine microbiome consists of a more dynamic microbial environment. It is intricately linked to a wide range of medical conditions and plays a pivotal role in maintaining overall health, with a direct impact on digestion, metabolism, brain function and immune system regulation. The small intestine microbiome is particularly significant in the context of drug metabolism and the body's response to various therapies, making it a crucial area of study for developing targeted treatments and understanding gastrointestinal health.
Digestion
Absorbs nutrients from food into the bloodstream
Immune system
Small intestine supports immunity by producing antimicrobial peptides
Drug metabolism
90% of drug absorption occurs in the small intestine
Gut-brain axis
Signals from the gut influence brain function and vice versa
Our approach
Microvitality has developed a novel capsule that provides precise, non-invasive, and uncontaminated sampling of the small intestine
Our capsule technology is designed to provide best-in-class small intestine data through a fluid biopsy across scientific disciplines, enabling groundbreaking microbiome discoveries and targeted therapeutic approaches
Minimally disruptive solution, capturing essential gut health data effortlessly, while ensuring patient comfort without the need for invasive procedures
Proprietary self-locking mechanism ensuring no contamination in the large intestine, providing a clear image of the small intestine microbiota
pH-dependent dissolution of enteric coating allows the capsule to bypass the stomach’s acidity and begin sampling once the small intestine has been reached
Enabling precise and controlled sampling
Delivering non-invasive and safe sampling
Ensuring reliable and uncontaminated data
Enabling precise and controlled sampling
Your partner in microbiome research
Microvitality’s approach to small intestine sampling is transforming microbiome research into actionable insights
Pharmaceutical companies
Will Gaybrick
Eileen O'Mara
Discover and validate novel microbiome biomarkers from the small intestine
Biomarker discovery
Uncover insights into how host-microbiome relationships impact health, disease progression, and therapeutic outcomes
Host-microbiome research
Enable precise sampling of the small intestine microbiome for early detection and diagnosis of gastrointestinal diseases
Diagnostics
Explore the relationship between the small intestine and neurological conditions
Gut-brain axis
Research in food science correlating products and tailored dietary interventions to the small intestine
Nutrition
Pharmacomicrobiomics profiling for clinical trial optimization and treatment efficacy
Precision medicine